Clinical Trial Update: Use of a Lifeline Graft in the A-V Shunt Model [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the Lifeline Graft for arteriovenous shunt use in patients with end-stage renal disease on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Lifeline Graft

Snippet

Sponsor: Cytograft Tissue Engineering | Conditions: ESRD, Hemodialysis | Phase 1, Phase 2 | Status: COMPLETED